Literature DB >> 18754812

Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo.

Olivier Jaen1, Sandrine Rullé, Natacha Bessis, Abokouo Zago, Marie-Christophe Boissier, Géraldine Falgarone.   

Abstract

Dendritic cells (DCs) mediate interactions between innate and specific immunity and may induce regulatory mechanisms. We investigated the effects of modulated DCs in mice with collagen-induced arthritis (CIA) and tested the responses of cells to induced naturally occurring regulatory T cells. DCs were stimulated or not with DNA or lipopolysaccharide (LPS) for 24 hr. DC maturation was assayed, and then modulated DCs were intraperitoneally injected on day 14 into DBA/1 mice to treat CIA. In addition to arthritis scores and type 2 collagen (CII) response, the induction of CD4(+) CD25(+) T cells was analysed by flow cytometry in peripheral blood and the expression of Foxp3, transforming growth factor (TGF)-beta, interleukin (IL)-10 and cytotoxic T-lymphocyte antigen (CTLA)-4 was quantified. Finally, the expression of indoleamine-2,3-dioxygenase (IDO) was assayed in DCs. In comparison with LPS-stimulated DCs, plasmid-stimulated DCs expressed lower levels of major histocompatibility complex (MHC) class II, CD40, CD80 and CD86 molecules and secreted less IL-12p70, interferon (IFN)-gamma, IL-10 and TNF-alpha, displaying a semi-mature phenotype. Compared with non-stimulated DCs, stimulated DCs improved arthritis scores when injected after immunization, without modifying the T helper type 1 (Th1)/Th2 balance of the immune response against collagen. Stimulated DCs induced markers for regulatory T cells (Foxp3, TGF-beta1 and CTLA-4) in vivo. Only LPS-stimulated DCs expressed IDO, which may explain their better therapeutic efficacy. Regulatory mechanisms were induced using DCs modulated by innate immunity stimulators. Innate immunity mechanisms do not require the presence of the disease-causing antigen, even in T- and B-cell specific diseases. Our results have implications for the treatment of rheumatoid arthritis, an autoimmune disease whose triggering antigen has not been identified, and substantially clarify the role of regulatory T cells in CIA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754812      PMCID: PMC2632710          DOI: 10.1111/j.1365-2567.2008.02875.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function.

Authors:  Carine Brinster; Ethan M Shevach
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

Review 2.  Regulatory T cells.

Authors:  Stefan Beissert; Agatha Schwarz; Thomas Schwarz
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

Review 3.  Regulation of immunity by self-reactive T cells.

Authors:  Mitchell Kronenberg; Alexander Rudensky
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

4.  Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells.

Authors:  Louis-Marie Charbonnier; Leonie M van Duivenvoorde; Florence Apparailly; Céline Cantos; Wanda G H Han; Danièle Noël; Christophe Duperray; Tom W J Huizinga; René E M Toes; Christian Jorgensen; Pascale Louis-Plence
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

5.  Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.

Authors:  Gerhard Wingender; Natalio Garbi; Beatrix Schumak; Frank Jüngerkes; Elmar Endl; Dagmar von Bubnoff; Julia Steitz; Jörg Striegler; Gerd Moldenhauer; Thomas Tüting; Antje Heit; Katharina M Huster; Osamu Takikawa; Shizuo Akira; Dirk H Busch; Hermann Wagner; Günter J Hämmerling; Percy A Knolle; Andreas Limmer
Journal:  Eur J Immunol       Date:  2006-01       Impact factor: 5.532

Review 6.  Where do T cells stand in rheumatoid arthritis?

Authors:  Catherine Fournier
Journal:  Joint Bone Spine       Date:  2005-06-29       Impact factor: 4.929

Review 7.  Role for innate immunity in rheumatoid arthritis.

Authors:  Géraldine Falgarone; Olivier Jaen; Marie-Christophe Boissier
Journal:  Joint Bone Spine       Date:  2005-01       Impact factor: 4.929

8.  Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.

Authors:  Andrew L Mellor; Babak Baban; Phillip R Chandler; Anna Manlapat; David J Kahler; David H Munn
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

Review 9.  Role of regulatory T cells in experimental arthritis and implications for clinical use.

Authors:  Marco Londei
Journal:  Arthritis Res Ther       Date:  2005-04-07       Impact factor: 5.156

10.  Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma.

Authors:  Hilde Kelchtermans; Bert De Klerck; Tania Mitera; Maarten Van Balen; Dominique Bullens; Alfons Billiau; Georges Leclercq; Patrick Matthys
Journal:  Arthritis Res Ther       Date:  2005-01-28       Impact factor: 5.156

View more
  29 in total

Review 1.  Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.

Authors:  G C Prendergast; M Y Chang; L Mandik-Nayak; R Metz; A J Muller
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 2.  Myeloid Populations in Systemic Autoimmune Diseases.

Authors:  María Morell; Nieves Varela; Concepción Marañón
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

3.  The protein LJM 111 from Lutzomyia longipalpis salivary gland extract (SGE) accounts for the SGE-inhibitory effects upon inflammatory parameters in experimental arthritis model.

Authors:  Renata Grespan; Henrique P Lemos; Vanessa Carregaro; Waldiceu A Verri; Fabricio O Souto; Carlo J F de Oliveira; Clarissa Teixeira; José Marcos Ribeiro; Jesus G Valenzuela; Fernando Q Cunha
Journal:  Int Immunopharmacol       Date:  2012-02-21       Impact factor: 4.932

Review 4.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Authors:  Tracy L McGaha; Lei Huang; Henrique Lemos; Richard Metz; Mario Mautino; George C Prendergast; Andrew L Mellor
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

5.  TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin.

Authors:  Gyorgy Nagyeri; Marianna Radacs; Sheida Ghassemi-Nejad; Beata Tryniszewska; Katalin Olasz; Gabor Hutas; Zsuzsa Gyorfy; Vincent C Hascall; Tibor T Glant; Katalin Mikecz
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

6.  Adrenomedullin, a neuropeptide with immunoregulatory properties induces semi-mature tolerogenic dendritic cells.

Authors:  Sandrine Rullé; Marie-Dominique Ah Kioon; Carine Asensio; Julie Mussard; Hang-Korng Ea; Marie-Christophe Boissier; Frédéric Lioté; Géraldine Falgarone
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

Review 7.  Tolerogenic dendritic cells and their role in transplantation.

Authors:  Mohamed Ezzelarab; Angus W Thomson
Journal:  Semin Immunol       Date:  2011-07-07       Impact factor: 11.130

Review 8.  Gene Therapy for Autoimmune Disease.

Authors:  Shang-An Shu; Jinjun Wang; Mi-Hua Tao; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 9.  Hypoxia and Mucosal Inflammation.

Authors:  Sean P Colgan; Eric L Campbell; Douglas J Kominsky
Journal:  Annu Rev Pathol       Date:  2016-05-23       Impact factor: 23.472

10.  Systemic administration of tolerogenic dendritic cells ameliorates murine inflammatory arthritis.

Authors:  Louise J Healy; Helen L Collins; Stephen J Thompson
Journal:  Open Rheumatol J       Date:  2008-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.